A panel of the US Food and Drug Administration (FDA) experts voted 17-4 while favoring that benefits of taking Pfizer and BioNTech's coronavirus (COVID-19) vaccine outweigh the known risks in adults aged 16 years and older.
While the vote authorizes the vaccine usage for emergency usage, the FDA’s official stamp is still awaited, which is likely imminent, before the doctors start using the key drug.
With this, the US joins the line of the UK, Bahrain and Canada while approving (almost) the use of the famous covid vaccine for the pandemic’s cure. Moderna’s covid vaccine will be the next candidate for the US FDA’s approval, around December 17.
FX implications
Although the news is risk-positive, market players already knew about the same and have priced-in. As a result, AUD/USD remains strong near the highest in 30 months while moving a little on the announcement.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.
If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.
FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.
The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.
Recommended content
Editors’ Picks
AUD/USD stays pressured near 0.6500 as Trump tariffs threat outweighs upbeat data
AUD/USD stays under pressure near 0.6500 in Asian trading on Monday. The pair remains weighed down by a flight to safety in the US Dollar amid US President-elect Trump's fresh tariffs threat on BRICS, which offset better-than-expected Australian Retail Sales data and Chinese Caixin Manufacturing PMI.
USD/JPY retakes 150.50 on trade war fears-led US Dollar rebound
USD/JPY stages a goodish recovery from over a one-month low to test 150.50 in Monday Asian session. The pair rebounds amid a pickup in the USD demand. Trump's tariff threats and geopolitical risks benefit the safe-haven US Dollar while the Japanese Yen struggles amid BoJ's rate hike uncertainty.
Gold turns south below $2,650 as US Dollar jumps on Trump tariffs threat
Gold price edges lower below $2,650 in the Asian session on Monday. A recovery in the US Dollar weighs on the precious metal. Persistent geopolitical tensions and Trunp's fresh tariffs threat on BRICS revives the US Dollar's haven demand, weighing on the USD-denominated bright metal.
Week ahead: Traders lock gaze on NFP after Thanksgiving holiday
Will the NFP data corroborate bets of a Fed pause? Loonie traders await employment numbers as well. Australia’s GDP to verify whether bets of May RBA cut are realistic. Euro could take directions from ECB President Lagarde.
Eurozone PMI sounds the alarm about growth once more
The composite PMI dropped from 50 to 48.1, once more stressing growth concerns for the eurozone. Hard data has actually come in better than expected recently – so ahead of the December meeting, the ECB has to figure out whether this is the PMI crying wolf or whether it should take this signal seriously. We think it’s the latter.
Best Forex Brokers with Low Spreads
VERIFIED Low spreads are crucial for reducing trading costs. Explore top Forex brokers offering competitive spreads and high leverage. Compare options for EUR/USD, GBP/USD, USD/JPY, and Gold.